# OnCo record nct07596290 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07596290/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07596290", "NCT07596290" ;
  schema:name "Yang et al. Anti-PD-1/CTLA-4 Dual Immunotherapy for LARC"@en ;
  schema:alternateName "RADICAL"@en ;
  schema:description "A phase 2/3 trial in colorectal cancer, run by Beijing Friendship Hospital, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07596290/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07596290> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/> .